Clinical Trial Update: DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating diastolic improvement with carvedilol and empagliflozin in patients with cirrhosis, including cirrhotic cardiomyopathy; recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Cirrhotic Cardiomyopathy

Drugs mentioned

• CARVEDILOL (Carvedilol)
• Empagliflozin (empagliflozin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Cirrhotic Cardiomyopathy, Empagliflozin | Phase 4 | Status: RECRUITING